We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Immune EVaders: The Next Generation Therapeutic Agent With Amy Kauffman

From COVID to chronic infections and cancer, stem cell-derived extracellular vesicles (EVs) have the potential to change the landscape of regenerative medicine and inflammatory conditions treatments. Though still in early-stage research, EVs already appear to hold great promise.

This Teach Me in 10 will cover what EVs are, the therapeutic promise they hold as well as guidance on how to culture and scale. 

Dr. Kauffman recommends taking a look at the following resources:

Brought to you by